METHOD FOR PREDICTING GESTOSIS DEVELOPMENT IN EARLY PREGNANCY PERIOD

METHOD FOR PREDICTING GESTOSIS DEVELOPMENT IN EARLY PREGNANCY PERIOD

medicine. SUBSTANCE: method involves determining hemostasis constants in pregnant women at the first half of gestation period. Endotheliocyte system is studied by counting the number of circulating unbound endotheliocytes in pregnant woman blood. Willebrandt factor as hemostasis index is determined...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JURCHENKO L.N, MEDVINSKIJ I.D, MAZUROV A.D
Format: Patent
Sprache:eng
Schlagworte:
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JURCHENKO L.N
MEDVINSKIJ I.D
MAZUROV A.D
description medicine. SUBSTANCE: method involves determining hemostasis constants in pregnant women at the first half of gestation period. Endotheliocyte system is studied by counting the number of circulating unbound endotheliocytes in pregnant woman blood. Willebrandt factor as hemostasis index is determined and diagnostic index P is calculated from formula: P = 0,018.K1+0,044.K2, where K1 is the Willebrandt factor (%), and K2 is the number of unbound endotheliocytes (x 10 x 4/l). The P value being greater than zero, gestosis development is predicted. The P value being less than zero, physiological pregnancy development is predicted. EFFECT: enhanced effectiveness in determining group of risk and making decision concerning etiopathogenic therapy to be applied.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2154823C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2154823C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2154823C13</originalsourceid><addsrcrecordid>eNrjZHDxdQ3x8HdRcPMPUggIcnXxdA7x9HNXcHcNDvEP9gxWcHENc_XxD_B19QtR8PRTcHUM8okEKXT3c_RzBrJcgzz9XXgYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxQqJGhqYmFkbGzoTERSgAdICuw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR PREDICTING GESTOSIS DEVELOPMENT IN EARLY PREGNANCY PERIOD</title><source>esp@cenet</source><creator>JURCHENKO L.N ; MEDVINSKIJ I.D ; MAZUROV A.D</creator><creatorcontrib>JURCHENKO L.N ; MEDVINSKIJ I.D ; MAZUROV A.D</creatorcontrib><description>medicine. SUBSTANCE: method involves determining hemostasis constants in pregnant women at the first half of gestation period. Endotheliocyte system is studied by counting the number of circulating unbound endotheliocytes in pregnant woman blood. Willebrandt factor as hemostasis index is determined and diagnostic index P is calculated from formula: P = 0,018.K1+0,044.K2, where K1 is the Willebrandt factor (%), and K2 is the number of unbound endotheliocytes (x 10 x 4/l). The P value being greater than zero, gestosis development is predicted. The P value being less than zero, physiological pregnancy development is predicted. EFFECT: enhanced effectiveness in determining group of risk and making decision concerning etiopathogenic therapy to be applied.</description><edition>7</edition><language>eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2000</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20000820&amp;DB=EPODOC&amp;CC=RU&amp;NR=2154823C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20000820&amp;DB=EPODOC&amp;CC=RU&amp;NR=2154823C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JURCHENKO L.N</creatorcontrib><creatorcontrib>MEDVINSKIJ I.D</creatorcontrib><creatorcontrib>MAZUROV A.D</creatorcontrib><title>METHOD FOR PREDICTING GESTOSIS DEVELOPMENT IN EARLY PREGNANCY PERIOD</title><description>medicine. SUBSTANCE: method involves determining hemostasis constants in pregnant women at the first half of gestation period. Endotheliocyte system is studied by counting the number of circulating unbound endotheliocytes in pregnant woman blood. Willebrandt factor as hemostasis index is determined and diagnostic index P is calculated from formula: P = 0,018.K1+0,044.K2, where K1 is the Willebrandt factor (%), and K2 is the number of unbound endotheliocytes (x 10 x 4/l). The P value being greater than zero, gestosis development is predicted. The P value being less than zero, physiological pregnancy development is predicted. EFFECT: enhanced effectiveness in determining group of risk and making decision concerning etiopathogenic therapy to be applied.</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2000</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDxdQ3x8HdRcPMPUggIcnXxdA7x9HNXcHcNDvEP9gxWcHENc_XxD_B19QtR8PRTcHUM8okEKXT3c_RzBrJcgzz9XXgYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXxQqJGhqYmFkbGzoTERSgAdICuw</recordid><startdate>20000820</startdate><enddate>20000820</enddate><creator>JURCHENKO L.N</creator><creator>MEDVINSKIJ I.D</creator><creator>MAZUROV A.D</creator><scope>EVB</scope></search><sort><creationdate>20000820</creationdate><title>METHOD FOR PREDICTING GESTOSIS DEVELOPMENT IN EARLY PREGNANCY PERIOD</title><author>JURCHENKO L.N ; MEDVINSKIJ I.D ; MAZUROV A.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2154823C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2000</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>JURCHENKO L.N</creatorcontrib><creatorcontrib>MEDVINSKIJ I.D</creatorcontrib><creatorcontrib>MAZUROV A.D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JURCHENKO L.N</au><au>MEDVINSKIJ I.D</au><au>MAZUROV A.D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR PREDICTING GESTOSIS DEVELOPMENT IN EARLY PREGNANCY PERIOD</title><date>2000-08-20</date><risdate>2000</risdate><abstract>medicine. SUBSTANCE: method involves determining hemostasis constants in pregnant women at the first half of gestation period. Endotheliocyte system is studied by counting the number of circulating unbound endotheliocytes in pregnant woman blood. Willebrandt factor as hemostasis index is determined and diagnostic index P is calculated from formula: P = 0,018.K1+0,044.K2, where K1 is the Willebrandt factor (%), and K2 is the number of unbound endotheliocytes (x 10 x 4/l). The P value being greater than zero, gestosis development is predicted. The P value being less than zero, physiological pregnancy development is predicted. EFFECT: enhanced effectiveness in determining group of risk and making decision concerning etiopathogenic therapy to be applied.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_RU2154823C1
source esp@cenet
subjects INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
title METHOD FOR PREDICTING GESTOSIS DEVELOPMENT IN EARLY PREGNANCY PERIOD
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T19%3A07%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JURCHENKO%20L.N&rft.date=2000-08-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2154823C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true